TherapeuticsMD CEO Robert Finizio's 2018 pay slips 9% to $2.7M
TherapeuticsMD reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
TherapeuticsMD reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, five executives at TherapeuticsMD received on average a compensation package of $1.5M, a 5% decrease compared to previous year.
Average pay of disclosed executives at TherapeuticsMD
Robert G. Finizio, Chief Executive Officer, received $2.7M in total, which decreased by 9% compared to 2017. 50% of Finizio's compensation, or $1.4M, was in option awards. Finizio also received $150K in bonus, $600K in non-equity incentive plan, $600K in salary, as well as $18K in other compensation.
John C.K. Milligan, IV, Secretary, received a compensation package of $1.7M, which decreased by 8% compared to previous year. 49% of the compensation package, or $832K, was in option awards.
Daniel A. Cartwright, Chief Financial Officer, earned $1.2M in 2018, a 8% decrease compared to previous year.
Mitchell L. Krassan, Chief Strategy Performance Officer, received $1.1M in 2018, which decreases by 8% compared to 2017.
Michael Donegan, Vice President - Finance, earned $703K in 2018, a 32% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2019.